David J. Wambeke, Chief Business Officer at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC), bought 1,000,000 shares at $0.67 ($670K) on 2026-03-01, disclosed to the SEC on 2026-03-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| DMAC | BUY | 2023-06-26 | $300K | — | Filing → |
| DMAC | BUY | 2023-04-11 | $750K | — | Filing → |